Principles and key elements of the evidence base formation within assessment and classification of hazards posed by chemical substances

View or download the full article: 
PDF icon health-risk-analysis-2025-4-1.pdf
UDC: 
614.3; 615.9
DOI: 
10.21668/health.risk/2025.4.01.eng
Authors: 

Kh.Kh. Khamidulina1,2, E.V. Tarasova1, A.K. Nazarenko1, A.S. Tverskaya1, E.V. Dorofeeva1, I.V. Zamkova1, A.S. Proskurina1,2, D.N. Rabikova1,2, M.L. Lastovetskiy1, I.N. Araslanov1, Yu.Yu. Aniskova1, P.E. Balashov1

Organization: 

1Scientific Information and Analytical Center Russian Register of Potentially Hazardous Chemical and Biological Substances of the F.F. Erisman Federal Scientific Center of Hygiene of Rospotrebnadzor, 8 Bagrationovskii proezd, build. 2, Moscow, 121087, Russian Federation
2Russian Medical Academy of Continuous Professional Education, 2/1 Barrikadnaya Str., build. 1, Moscow, 125993, Russian Federation

Abstract: 

The demand for creating an evidence base in preventive toxicology is caused by the necessity to implement the criteria for assessing the hazard of chemical substances and mixtures for all types of exposure in the states of the Eurasian Economic Union. This should be done in accordance with the Globally Harmonized System of Classification and Labelling of Chemicals.

The aim of this study is to develop a scientifically substantiated unified action algorithm for creating an evidence base of the accepted assessments based on an integrated approach and transparency.
We analyzed international approaches to evidence base formation in toxicology by the WHO, the OECD, the European Union, as well as national methodological documents on assessment and classification of hazards posed by mutagens, endocrine disruptors, reprotoxicants, and skin and respiratory sensitizers. The weight of evidence was ranked based on the Klimish approach.

A unified decision-making algorithm has been developed and scientifically substantiated. It is a formalized scheme for systematic assessment of a set of evidence (both confirming and refuting the presence of an effect), taking their weight into account. The algorithm is based on key criteria: reliability, consistency, biological plausibility, dose-response relationship, and the comparability of animal studies with potential human health effects. The weight of evidence is assessed using a three-point scale based on the Klimisch approach. Priority is given to data with the lowest number of points, which helps increase objectivity and transparency in assessment and classification of chemical hazards. The proposed algorithm will contribute to improving the quality, reliability, and transparency of toxicological research, as well as the effectiveness and efficiency of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing ensuring sanitary and epidemiological welfare.

Keywords: 
evidence base, weight of evidence, decision-making algorithm, hazard classification, chemical substance, Klimisch approach, dependence, dose-effect
Khamidulina Kh.Kh., Tarasova E.V., Nazarenko A.K., Tverskaya A.S., Dorofeeva E.V., Zamkova I.V., Proskurina A.S., Rabikova D.N., Lastovetskiy M.L., Araslanov I.N., Aniskova Yu.Yu., Balashov P.E. Principles and key elements of the evidence base formation within assessment and classification of hazards posed by chemical substances. Health Risk Analysis, 2025, no. 4, pp. 4–12. DOI: 10.21668/health.risk/2025.4.01.eng
References: 
  1. Engalycheva G.N., Syubaev R.D. WoE analysis and key risk factors in preclinical development of medicinal products: a review. Bezopasnost’ i risk farmakoterapii, 2024, vol. 12, no. 4, pp. 463–476. DOI: 10.30895/2312-7821-2024-12-4-463-476 (in Russian).
  2. Martin P., Bladier C., Meek B., Bruyere O., Feinblatt E., Touvier M., Watier L., Makowski D. Weight of Evidence for Hazard Identification: A Critical Review of the Literature. Environ. Health Perspect., 2018, vol. 126, no. 7, pp. 076001. DOI: 10.1289/EHP3067
  3. Klimisch H.J., Andreae M., Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol., 1997, vol. 25, no. 1, pp. 1–5. DOI: 10.1006/rtph.1996.1076
  4. Khamidulina Kh.Kh., Rabikova D.N., Tarasova E.V., Sinitskaya T.A., Zamkova I.V.,
    Nazarenko A.K. Modern approaches to the assessment and classification of the hazard posed by
    substances with mutagenic effects. Health Risk Analysis, 2024, no. 4, pp. 4–13. DOI: 10.21668/health.risk/2024.4.01.eng
  5. Lee K.-C., Guiney P.D., Menzie C.A., Belanger S.E. Advancing the weight of evidence
    approach to enable chemical environmental risk assessment for decision-making and achieving
    protection goals. Integr. Environ. Assess. Manag., 2023, vol. 19, no. 5, pp. 1188–1191. DOI: 10.1002/ieam.4803
  6. Wolffe T.A.M., Vidler J., Halsall C., Hunt N., Whaley P. A Survey of Systematic Evidence Mapping Practice and the Case for Knowledge Graphs in Environmental Health and Toxicology. Toxicol. Sci., 2020, vol. 175, no. 1, pp. 35–49. DOI: 10.1093/toxsci/kfaa025
  7. Chinen K., Malloy T. Multi-Strategy Assessment of Different Uses of QSAR under REACH Analysis of Alternatives to Advance Information Transparency. Int. J. Environ. Res. Public Health, 2022, vol. 19, no. 7, pp. 4338. DOI: 10.3390/ijerph19074338
  8. Pawar G., Madden J.C., Ebbrell D., Firman J.W., Cronin M.T.D. In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR. Front. Pharmacol., 2019, vol. 10, pp. 561. DOI: 10.3389/fphar.2019.00561
  9. Hoffmann S., Aiassa E., Angrish M., Beausoleil C., Bois F.Y., Ciccolallo L., Craig P.S.,
    De Vries R.B.M. [et al.]. Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks. ALTEX, 2022, vol. 39, no. 3, pp. 499–518. DOI: 10.14573/altex.2202141
  10. Waspe J., Bui T., Dishaw L., Kraft A., Luke A., Beronius A. Evaluating reliability and
    risk of bias of in vivo animal data for risk assessment of chemicals – Exploring the use of the Sci-RAP tool in a systematic review context. Environ. Int., 2021, vol. 146, pp. 106103. DOI: 10.1016/j.envint.2020.106103
  11. Davenport R., Curtis-Jackson P., Dalkmann P., Davies J., Fenner K., Hand L., McDonough K., Ott A. [et al.]. Scientific concepts and methods for moving persistence assessments into the 21st century. Integr. Environ. Assess. Manag., 2022, vol. 18, no. 6, pp. 1454–1487. DOI: 10.1002/ieam.4575
  12. Vandenberg L.N., Pelch K.E. Systematic Review Methodologies and Endocrine Disrupting Chemicals: Improving Evaluations of the Plastic Monomer Bisphenol A. Endocr. Metab. Immune Disord. Drug Targets, 2022, vol. 22, no. 7, pp. 748–764. DOI: 10.2174/1871530321666211005163614
  13. Catlin N.R., Cappon G.D., Davenport S.D., Stethem C.M., Nowland W.S., Campion S.N., Bowman C.J. New approach methodologies to confirm developmental toxicity of pharmaceuticals based on weight of evidence. Reprod. Toxicol., 2024, vol. 129, pp. 108686. DOI: 10.1016/j.reprotox.2024.108686
  14. Basei G., Zabeo A., Rasmussen K., Tsiliki G., Hristozov D. A Weight of Evidence approach to classify nanomaterials according to the EU Classification, Labelling and Packaging Regulation criteria. NanoImpact, 2021, vol. 24, pp. 100359. DOI: 10.1016/j.impact.2021.100359
  15. Lee I., Na M., Lavelle M., Api A.M. Derivation of the no expected sensitization induction level for dermal quantitative risk assessment of fragrance ingredients using a weight of evidence approach. Food Chem. Toxicol., 2022, vol. 159, pp. 112705. DOI: 10.1016/j.fct.2021.112705
  16. Kumari M., Kumar A. Identification of component-based approach for prediction of joint chemical mixture toxicity risk assessment with respect to human health: A critical review. Food Chem. Toxicol., 2020, vol. 143, pp. 111458. DOI: 10.1016/j.fct.2020.111458
  17. Gilmour N., Reynolds J., Przybylak K., Aleksic M., Aptula N., Baltazar M.T., Cubberley R., Rajagopal R. [et al.]. Next generation risk assessment for skin allergy: Decision making using new approach methodologies. Regul. Toxicol. Pharmacol., 2022, vol. 131, pp. 105159. DOI: 10.1016/j.yrtph.2022.105159
  18. Chien H.-T., Roos P., Russel F.G.M., Theunissen P.T., van Meer P.J.K. The use of weight-of-evidence approaches to characterize developmental toxicity risk for therapeutic monoclonal antibodies in humans without in vivo studies. Regul. Toxicol. Pharmacol., 2024, vol. 152, pp. 105682. DOI: 10.1016/j.yrtph.2024.105682
  19. Money C.D., Tomenson J.A., Penman M.G., Boogaard P.J., Lewis R.J. A systematic ap-proach for evaluating and scoring human data. Regul. Toxicol. Pharmacol., 2013, vol. 66, no. 2, pp. 241–247. DOI: 10.1016/j.yrtph.2013.03.011
  20. Proskurina A.S., Khamidulina Kh.Kh., Tarasova E.V. International approaches to reducing the risk of highly hazardous chemicals exposure on human health and to the selection criteria for substitution by safer analogues (literature review). Toksikologicheskii vestnik, 2022, vol. 30, no. 2, pp. 68–78. DOI: 10.47470/0869-7922-2022-30-2-68-78 (in Russian).
Received: 
14.11.2025
Approved: 
02.12.2025
Accepted for publication: 
26.12.2025

You are here

Home